Volume 19, Issue 11 e202200557
Research Article

Anticholinesterase Compounds from Endemic Prangos uechtritzii

Gokay Albayrak

Gokay Albayrak

Department of Pharmaceutical Botany, Faculty of Pharmacy, İzmir Katip Çelebi University, 35620 İzmir, Turkey

Department of Pharmaceutical Botany, Faculty of Pharmacy, Ege University, 35040 İzmir, Turkey

Search for more papers by this author
Serdar Demir

Serdar Demir

Department of Pharmaceutical Botany, Faculty of Pharmacy, Ege University, 35040 İzmir, Turkey

Search for more papers by this author
Halil Koyu

Halil Koyu

Department of Pharmaceutical Botany, Faculty of Pharmacy, İzmir Katip Çelebi University, 35620 İzmir, Turkey

Search for more papers by this author
Sura Baykan

Corresponding Author

Sura Baykan

Department of Pharmaceutical Botany, Faculty of Pharmacy, Ege University, 35040 İzmir, Turkey

Search for more papers by this author
First published: 06 October 2022
Citations: 2

Abstract

In this study, the anticholinesterase effects of the extracts and isolated compounds from the roots of endemic Prangos uechtritzii Boiss & Hausskn (Apiaceae) are reported. A novel polyacetylenic compound; (+)-8-O-methyloplopantriol A along with two known polyacetylenes; (−)-panaxynol, (+)-falcarindiol and fifteen known coumarin derivatives; umbelliferone, 6-formylumbelliferone, suberosin, 7-demethylsuberosin, (+)-ulopterol, tamarin, psoralen, imperatorin, (+)-oxypeucedanin, (+)-oxypeucedanin hydrate, (+)-oxypeucedanin methanolate, (+)-marmesin, (−)-prantschimgin, (+)-decursinol, and (−)-adicardin were isolated from the hexane (Pu-HE), chloroform (Pu-CE), and methanol (Pu-ME) extracts of P. uechtritzii roots. (−)-Panaxynol, (+)-falcarindiol, 6-formylumbelliferone, (+)-decursinol, and (−)-adicardin were obtained from the genus Prangos for the first time. (+)-8-O-Methyloplopantriol A inhibited both AChE (IC50=194.5±5.8 μM) and BChE (IC50=51.9±2.96 μM) enzymes. (+)-Falcarindiol, 6-formylumbelliferone, 7-demethylsuberosin, tamarin, and imperatorin also exhibited BChE-specific inhibitory activities (IC50=27.88-93.86 μM). (+)-Falcarindiol (IC50=27.88±0.91 μM) and imperatorin (IC50=30.89±1.40 μM) as the most active components could be led compounds to develop new BChE inhibitors with further research against Alzheimer's disease.

Graphical Abstract

Conflict of interest

The authors declare no conflict of interest.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.